Cytek earnings
WebApr 8, 2024 · Cytek Biosciences Inc.’s market cap currently stands at around $1.18 billion, with investors looking forward to this quarter’s earnings report slated for Feb 28, 2024. Analysts project the company’s earnings per share (EPS) to be $0.03, which has seen fiscal year 2024 EPS growth forecast to increase to $0.21 and about $0.33 for fiscal ... WebApr 10, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 100% and 6.64%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stoc... 4 months ago - Zacks Investment Research Cytek Biosciences Reports Third Quarter 2024 Financial Results
Cytek earnings
Did you know?
WebSep 30, 2024 · Cytek Biosciences continues to expect full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the third quarter 2024 financial results on Wednesday, November 9, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. WebMay 11, 2024 · Other Ticker Details CTKB Company Name Cytek Biosciences Inc Earnings Call Date 11-05-2024 Time (ET) 17:00:00 Fiscal Quarter Q1 Fiscal Year
WebCytek Biosciences’s upcoming earnings report date is May 10, 2024 which is in 37 days. How were Cytek Biosciences’s earnings last quarter? Cytek Biosciences released its earnings results on Feb 28, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.042 by $0.018. ... WebCytek Biosciences, Inc. (CTKB) Q2 Earnings Surpass Estimates Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 50% and 2.85%, respectively, for the quarter ended June 2024.
WebApr 12, 2024 · Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript SA Transcripts Sat, Nov. 12, 2024 Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2024 Results Earnings Call Transcript... WebFeb 28, 2024 · Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Full year 2024 revenue increased 28%, or 34% on constant currency basis, compared to prior year Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024
WebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and …
WebCytek's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 955.5M. Over the last four quarters, Cytek's revenue has grown by 176.8%. … therapeutic relief hattiesburg msWebFeb 23, 2024 · Total revenue was $38.9 million for the fourth quarter and $128.0 million for the full year of 2024, representing 27% and 38% increases over the … therapeutic relationship nursing timesWebCytek Biosciences Reports Second Quarter 2024 Financial Results Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings... signs of hypermobility in childrenWebApr 12, 2024 · All earnings call transcripts on Cytek Biosciences, Inc. (CTKB) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides. therapeutic relationship rcnWebFeb 26, 2024 · Cytek Biosciences (NASDAQ:CTKB – Get Rating) is scheduled to release its earnings data after the market closes on Tuesday, February 28th.Analysts expect Cytek Biosciences to post earnings of $0.05 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.. Cytek Biosciences … signs of hyperglycemia in childWebApr 12, 2024 · On Tuesday, March 7th, Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock. The shares were sold at an average price of $10.13, for a total value of $202,600.00. signs of hyperglycemia vs hypoglycemiaWebMar 31, 2024 · Cytek Biosciences now expects full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information Cytek will host a conference call to discuss the first quarter 2024 financial results on Wednesday, May 11, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. therapeutic relationships definition